Inari Medical Inc (NARI) Company Profile & Statistics

Inari Medical Inc
NARI
(Nasdaq - US)
Closed
51.03
+0.20 (+0.39%)
in:usd•As of: Nov 27, 2024 15:59 UTC -5
After Market:51.23+0.20 (+0.39%)
Open
51.55
High
51.66
Low
50.62

About Inari Medical Inc

CEO

Andrew Hykes

Headquarters

6001 oak canyon, suite 100

irvine, ca 92618, united states

Auditor

BDO USA, P.C.

Employees

1,300

Share Holders

Website

www.inarimedical.com

Industry

medical specialties

Sector

health technology

Company Overview

Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S.

Inari Medical Inc Statistics

Valuation Measures

Market Capitalization ²	2.99B
Enterprise Value	2.95B
Enterprise Value/EBITDA (ttm)	-61.64
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	6.84
Price to Sales (ttm)	5.18
Price to Cash (ytd)	576.47

Profitability

Gross Margin (ttm)	86.82%
Operating Margin (ttm)	-7.78%
Profit Margin (ttm)	-13.48%
Return on Equity (ttm)	-10.09%
Return on Invested Capital (ttm)	-18.04%
Return on Assets (ttm)	-6.60%

Income Statement

Revenue (ttm)	574.50M
Revenue Per Share (ttm)	9.81
Gross Profit (ttm)	498.76M
EBITDA (ttm)³	-47.80M
Net Income Avi to Common (ttm)	-78.58M
Diluted EPS (ttm)	-1.35

Share Statistics

Beta (5Y Monthly)	0.96
52-Week Change	-12.45%
S&P500 52-Week Change	31.70%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	58.54M
Dividend Yield	0.00%
Float ⁴	52.34M
% Held by Insiders	10.60%
% Held by Institutions	90.98%

Balance Sheet

Total Cash (mrq)	111.61M
Total Cash Per Share (mrq)	1.91
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	1.77%
Quick Ratio (mrq)	1.40%
Book Value Per Share (mrq)	7.44

Cash Flow

Operating Cash Flow Per Share (ytd)	0.03
Free Cash Flow (ytd)	-8.26M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Inari Medical Inc

Trade With A Regulated Broker